Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study
Clinical trial NCT03379558 · TERMINATED
Trial details
- NCT number
- NCT03379558
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-12-19
- Primary completion
- 2020-09-04
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.